Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.25B |
| 2 |
Home Depot
HD
|
+$645M |
| 3 |
Gilead Sciences
GILD
|
+$621M |
| 4 |
Navient
NAVI
|
+$609M |
| 5 |
Exelon
EXC
|
+$583M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$1.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$611M |
| 3 |
SLM Corp
SLM
|
+$564M |
| 4 |
CIE
Cobalt International Energy, Inc
CIE
|
+$403M |
| 5 |
DuPont de Nemours
DD
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.18% |
| 2 | Financials | 7.69% |
| 3 | Technology | 7.67% |
| 4 | Healthcare | 6.64% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Invesco FTSE RAFI US 1000 ETF
PRF
$9.74B
| $4.8M | ﹤0.01% |
271,345
-441,395
| -62% | -$7.6M |
|
|
BLOX
3052
DELISTED
Infoblox Inc
BLOX
| $4.8M | ﹤0.01% |
364,966
+25,987
| +8% | +$445K |
|
|
MACK
3053
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $4.8M | ﹤0.01% |
83,655
+58,448
| +232% | +$2.97M |
|
3054
PUT
Northrop Grumman
NOC
$75.7B
| $4.8M | ﹤0.01% |
40,100
-1,800
| -4% | -$218K |
|
|
CTXS
3055
CALL
DELISTED
Citrix Systems Inc
CTXS
| $4.79M | ﹤0.01% |
96,194
+18,083
| +23% | +$869K |
|
|
AVG
3056
DELISTED
AVG Technologies N.V.
AVG
| $4.79M | ﹤0.01% |
237,925
+61,736
| +35% | +$1.22M |
|
|
AFFX
3057
PUT
DELISTED
Affymetrix Inc
AFFX
| $4.79M | ﹤0.01% |
537,600
-10,000
| -2% | -$79.6K |
|
|
VCRA
3058
CALL
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.78M | ﹤0.01% |
362,300
-564,300
| -61% | -$7.71M |
|
|
XEC
3059
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $4.78M | ﹤0.01% |
33,300
+9,200
| +38% | +$1.17M |
|
|
AUXL
3060
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $4.77M | ﹤0.01% |
237,734
-195,649
| -45% | -$4.49M |
|
|
FWLT
3061
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
| $4.77M | ﹤0.01% |
139,946
+29,889
| +27% | +$1.01M |
|
|
GRA
3062
PUT
DELISTED
W.R. Grace & Co.
GRA
| $4.76M | ﹤0.01% |
50,400
-8,300
| -14% | -$782K |
|
3063
PUT
Comstock Resources
CRK
$3.73B
| $4.76M | ﹤0.01% |
33,000
| – | – |
|
|
DATA
3064
DELISTED
Tableau Software, Inc.
DATA
| $4.76M | ﹤0.01% |
66,686
-129,083
| -66% | -$8.09M |
|
|
PNK
3065
DELISTED
Pinnacle Entertainment Inc.
PNK
| $4.75M | ﹤0.01% |
188,668
+5,694
| +3% | +$135K |
|
|
ARNA
3066
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.75M | ﹤0.01% |
80,976
-58,520
| -42% | -$3.68M |
|
|
OUTR
3067
PUT
DELISTED
OUTERWALL INC
OUTR
| $4.74M | ﹤0.01% |
79,800
-85,500
| -52% | -$5.78M |
|
3068
PUT
Dillards
DDS
$9.42B
| $4.73M | ﹤0.01% |
40,600
-23,300
| -36% | -$2.43M |
|
|
GZT
3069
DELISTED
Gazit-globe Ltd
GZT
| $4.73M | ﹤0.01% |
356,074
+277,776
| +355% | +$3.65M |
|
3070
Skywest
SKYW
$4.28B
| $4.72M | ﹤0.01% |
386,653
+1,385
| +0.4% | +$16.8K |
|
|
PETX
3071
DELISTED
Aratana Therapeutics, Inc.
PETX
| $4.72M | ﹤0.01% |
302,107
-16,285
| -5% | -$231K |
|
3072
United Microelectronic
UMC
$47.7B
| $4.71M | ﹤0.01% |
1,956,611
-109,010
| -5% | -$243K |
|
|
INXN
3073
CALL
DELISTED
Interxion Holding N.V.
INXN
| $4.71M | ﹤0.01% |
+172,100
| New | +$4.48M |
|
3074
CALL
BioCryst Pharmaceuticals
BCRX
$2.3B
| $4.71M | ﹤0.01% |
+369,500
| New | +$3.59M |
|
3075
PUT
NiSource
NI
$21.5B
| $4.71M | ﹤0.01% |
+304,637
| New | +$4.4M |
|
Similar funds
Goldman Sachs's Q2 2014 Portfolio in Review
As of Q2 2014, Goldman Sachs held 7,392 positions worth $319B, up 4.4% from $306B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs's Q2 2014 filing shows 646 new, 2,991 increased, 3,008 reduced and 432 closed positions. Its largest new stake was Navient: 36,826,072 shares worth $652M. The largest sale was State Street SPDR S&P Retail ETF, an estimated $1.17B.
By sector, the portfolio is most concentrated in Energy at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Technology.
- Goldman Sachs's largest Q2 2014 buy was Navient: 36,826,072 shares worth $652M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q2 2014, an estimated $1.25B increase.
- Goldman Sachs's biggest Q2 2014 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $1.17B.
- Goldman Sachs fully exited CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q2 2014, selling an estimated $59.8M.
- Goldman Sachs's ten largest holdings make up 13% of its $319B portfolio in Q2 2014.
- Goldman Sachs opened 646 new positions and closed 432 in Q2 2014.
- Goldman Sachs's portfolio value rose 4.4% quarter-over-quarter to $319B.
Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.